GlaxoSmithKline Pharmaceuticals Limited Share Price NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Delayed
NSE India S.E.
01:19:10 01/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,785.00 INR | +0.57% |
|
-1.79% | +12.33% |
| 03/08 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 03/08 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 47TCr 488.98Cr 430.6Cr 407.98Cr 368.32Cr 694.18Cr 703.16Cr 4.88TCr 1.88TCr 24TCr 1.84TCr 1.8TCr 77TCr | P/E 2027 * |
40.2x | P/E 2028 * | 35x |
|---|---|---|---|---|---|
| Enterprise Value | 47TCr 488.98Cr 430.6Cr 407.98Cr 368.32Cr 694.18Cr 703.16Cr 4.88TCr 1.88TCr 24TCr 1.84TCr 1.8TCr 77TCr | EV / Sales 2027 * |
11x | EV / Sales 2028 * | 9.92x |
| Free-Float |
24.37% | Yield 2027 * |
1.07% | Yield 2028 * | 1.07% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| GLAXO | Delayed | |
NSE India S.E.
| GLAXO | Delayed |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | +0.34% | ||
| 1 week | -1.79% | ||
| Current month | +0.34% | ||
| 1 month | -7.26% | ||
| 3 months | +12.74% | ||
| 6 months | +19.29% | ||
| Current year | +12.33% |
| 1 week | 2,724.8 |  | 2,987 |
| 1 month | 2,724.8 | | 3,075 |
| Current year | 2,088.1 | | 3,120.7 |
| 1 year | 2,088.1 | | 3,120.7 |
| 3 years | 1,385.05 | | 3,515.7 |
| 5 years | 1,227 | | 3,515.7 |
| 10 years | 962.65 | | 3,515.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 01/12/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 01/04/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 01/04/2019 |
| Director/Board Member | 59 | 18/05/2020 | |
Manu Anand
BRD | Director/Board Member | 67 | 16/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.57% | -1.79% | - | - | 488.98Cr | |
| -2.33% | +0.53% | +51.65% | +115.42% | 1,03100Cr | |
| -1.06% | -1.65% | +42.78% | +69.98% | 64TCr | |
| -0.65% | -1.32% | +12.98% | +75.49% | 46TCr | |
| -2.66% | -1.87% | +73.13% | +41.15% | 36TCr | |
| -0.43% | -5.04% | +22.25% | +39.13% | 33TCr | |
| -1.40% | -0.81% | +13.44% | +26.38% | 27TCr | |
| -1.45% | -2.48% | -2.77% | +10.43% | 25TCr | |
| -0.50% | +3.80% | +49.37% | +56.84% | 23TCr | |
| -1.47% | -1.53% | +34.28% | +98.89% | 18TCr | |
| Average | -0.84% | -0.36% | +33.01% | +59.30% | 41.82TCr | |
| Weighted average by Cap. | -1.10% | -0.35% | +37.41% | +71.07% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4.26TCr 44Cr 39Cr 37Cr 33Cr 63Cr 64Cr 443.18Cr 170.55Cr 2.18TCr 166.71Cr 163.07Cr 6.98TCr | 4.72TCr 49Cr 43Cr 41Cr 37Cr 70Cr 71Cr 491.83Cr 189.27Cr 2.42TCr 185.01Cr 180.97Cr 7.74TCr |
| Net income | 1.17TCr 12Cr 11Cr 10Cr 9.16Cr 17Cr 17Cr 121.33Cr 47Cr 595.79Cr 46Cr 45Cr 1.91TCr | 1.34TCr 14Cr 12Cr 12Cr 11Cr 20Cr 20Cr 139.7Cr 54Cr 685.95Cr 53Cr 51Cr 2.2TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/26/01 | ₹2,785.00 | +0.57% | 29,428 |
| 30/26/30 | ₹2,769.30 | -0.52% | 45,801 |
| 29/26/29 | ₹2,783.80 | -3.89% | 49,829 |
| 28/26/28 | ₹2,896.40 | +2.87% | 4,59,963 |
| 25/26/25 | ₹2,815.70 | -0.48% | 15,380 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
